Bengt Fellström

Recommendations for pre-analytical urine sample handling to allow optimal assessment of albuminuria and proteinuria

Ridderbos, Stefan; van Mil, Dominique; Fellström, Bengt; Gillespie, Barbara S. et al.

Ingår i Nephrology, Dialysis and Transplantation, 2026

• DOI för Recommendations for pre-analytical urine sample handling to allow optimal assessment of albuminuria and proteinuria
• Ladda ner fulltext (pdf) av Recommendations for pre-analytical urine sample handling to allow optimal assessment of albuminuria and proteinuria

Reconsidering the measurement of urinary proteins in chronic kidney disease: towards a global consensus on albuminuria assessment

Heerspink, Hiddo J. L.; Fellström, Bengt; Wanner, Christoph; Gansevoort, Ron T.

Ingår i Nephrology, Dialysis and Transplantation, 2026

• DOI för Reconsidering the measurement of urinary proteins in chronic kidney disease: towards a global consensus on albuminuria assessment
• Ladda ner fulltext (pdf) av Reconsidering the measurement of urinary proteins in chronic kidney disease: towards a global consensus on albuminuria assessment

An exploration of markers of microvascular dysfunction in kidney transplant recipients randomized to belatacept: no clinical impact of CNIs on endothelial function

Bredewold, Edwin O. W.; Postma, Rudmer J.; Chan, Joe; Svensson, My H. S. et al.

Ingår i FRONTIERS IN TRANSPLANTATION, 2026

• DOI för An exploration of markers of microvascular dysfunction in kidney transplant recipients randomized to belatacept: no clinical impact of CNIs on endothelial function
• Ladda ner fulltext (pdf) av An exploration of markers of microvascular dysfunction in kidney transplant recipients randomized to belatacept: no clinical impact of CNIs on endothelial function

Different eGFR markers and prediction of cardiovascular risk

Tydén, Maria; Batra, Gorav; Fellström, Bengt; Held, Claes et al.

Ingår i Journal of Internal Medicine, s. 143-157, 2026

• DOI för Different eGFR markers and prediction of cardiovascular risk
• Ladda ner fulltext (pdf) av Different eGFR markers and prediction of cardiovascular risk

Troponin I is an independent predictor of cardiovascular events and mortality in haemodialysis patients

Tydén, Maria; Westerlund, Magnus E.; Duarte, Kevin; Eriksson, Niclas et al.

Ingår i Clinical Kidney Journal, 2025

• DOI för Troponin I is an independent predictor of cardiovascular events and mortality in haemodialysis patients
• Ladda ner fulltext (pdf) av Troponin I is an independent predictor of cardiovascular events and mortality in haemodialysis patients

Reconsidering the measurement of urinary proteins in chronic kidney disease: towards a global consensus on albuminuria assessment

Heerspink, Hiddo J. L.; Fellström, Bengt; Wanner, Christoph; Gansevoort, Ron T.

Ingår i Nephrology, Dialysis and Transplantation, 2026

• DOI för Reconsidering the measurement of urinary proteins in chronic kidney disease: towards a global consensus on albuminuria assessment
• Ladda ner fulltext (pdf) av Reconsidering the measurement of urinary proteins in chronic kidney disease: towards a global consensus on albuminuria assessment

An exploration of markers of microvascular dysfunction in kidney transplant recipients randomized to belatacept: no clinical impact of CNIs on endothelial function

Bredewold, Edwin O. W.; Postma, Rudmer J.; Chan, Joe; Svensson, My H. S. et al.

Ingår i FRONTIERS IN TRANSPLANTATION, 2026

• DOI för An exploration of markers of microvascular dysfunction in kidney transplant recipients randomized to belatacept: no clinical impact of CNIs on endothelial function
• Ladda ner fulltext (pdf) av An exploration of markers of microvascular dysfunction in kidney transplant recipients randomized to belatacept: no clinical impact of CNIs on endothelial function

Different eGFR markers and prediction of cardiovascular risk

Tydén, Maria; Batra, Gorav; Fellström, Bengt; Held, Claes et al.

Ingår i Journal of Internal Medicine, s. 143-157, 2026

• DOI för Different eGFR markers and prediction of cardiovascular risk
• Ladda ner fulltext (pdf) av Different eGFR markers and prediction of cardiovascular risk

Troponin I is an independent predictor of cardiovascular events and mortality in haemodialysis patients

Tydén, Maria; Westerlund, Magnus E.; Duarte, Kevin; Eriksson, Niclas et al.

Ingår i Clinical Kidney Journal, 2025

• DOI för Troponin I is an independent predictor of cardiovascular events and mortality in haemodialysis patients
• Ladda ner fulltext (pdf) av Troponin I is an independent predictor of cardiovascular events and mortality in haemodialysis patients

IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial

Chertow, Glenn M.; Chang, Anna Marie; Felker, G. Michael; Heise, Mark et al.

Ingår i Nature Medicine, s. 2328-2336, 2024

• DOI för IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial
• Ladda ner fulltext (pdf) av IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial

Protective Effects of the Food Supplement Flexovital in a Model of Cardiovascular-Kidney-Metabolic Syndrome in Mice

Carvalho, Lucas Rannier Ribeiro Antonino; Tydén, Maria; Shimari, Miho; Zhuge, Zhengbing et al.

Ingår i Nutrients, 2024

• DOI för Protective Effects of the Food Supplement Flexovital in a Model of Cardiovascular-Kidney-Metabolic Syndrome in Mice
• Ladda ner fulltext (pdf) av Protective Effects of the Food Supplement Flexovital in a Model of Cardiovascular-Kidney-Metabolic Syndrome in Mice

Identification of endophenotypes supporting outcome prediction in hemodialysis patients based on mechanistic markers of statin treatment

Leierer, Johannes; Salib, Madonna; Evgeniou, Michail; Rossignol, Patrick et al.

Ingår i Heliyon, 2024

• DOI för Identification of endophenotypes supporting outcome prediction in hemodialysis patients based on mechanistic markers of statin treatment
• Ladda ner fulltext (pdf) av Identification of endophenotypes supporting outcome prediction in hemodialysis patients based on mechanistic markers of statin treatment

Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin A nephropathy: insights from the NEFIGAN trial

Wimbury, David; Muto, Masahiro; Bhachu, Jasraj S.; Scionti, Katrin et al.

Ingår i Kidney International, s. 381-388, 2024

• DOI för Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin A nephropathy: insights from the NEFIGAN trial
• Ladda ner fulltext (pdf) av Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin A nephropathy: insights from the NEFIGAN trial

A novel model of cardiovascular-kidney-metabolic syndrome combining unilateral nephrectomy and high-salt-sugar-fat diet in mice

Carvalho, Lucas Rannier R. A.; Shimari, Miho; Boeder, Ariela Maina; Zhuge, Zhengbing et al.

Ingår i Lab animal, s. 336-346, 2024

• DOI för A novel model of cardiovascular-kidney-metabolic syndrome combining unilateral nephrectomy and high-salt-sugar-fat diet in mice
• Ladda ner fulltext (pdf) av A novel model of cardiovascular-kidney-metabolic syndrome combining unilateral nephrectomy and high-salt-sugar-fat diet in mice

Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial

Bredewold, Obbo W; Chan, Joe; Svensson, My; Bruchfeld, Annette et al.

Ingår i Kidney Medicine, 2023

• DOI för Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial
• Ladda ner fulltext (pdf) av Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial

Budesonide delayed-release capsules to reduce proteinuria in adults with primary immunoglobulin A nephropathy

Barratt, Jonathan; Lafayette, Richard A.; Rovin, Brad H.; Fellström, Bengt

Ingår i Expert Review of Clinical Immunology, s. 699-710, 2023

• DOI för Budesonide delayed-release capsules to reduce proteinuria in adults with primary immunoglobulin A nephropathy
• Ladda ner fulltext (pdf) av Budesonide delayed-release capsules to reduce proteinuria in adults with primary immunoglobulin A nephropathy

NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patients

Rossignol, P; Duarte, K; Bresso, E; A, Åsberg et al.

Ingår i European Heart Journal Open, 2022

• DOI för NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patients
• Ladda ner fulltext (pdf) av NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patients

Novel Biomarkers Detected by Proteomics Predict Death and Cardiovascular Events in Hemodialysis Patients

Wu, Ping-Hsun; Glerup, Rie Io; Svensson, My Hanna Sofia; Eriksson, Niclas et al.

Ingår i Biomedicines, 2022

• DOI för Novel Biomarkers Detected by Proteomics Predict Death and Cardiovascular Events in Hemodialysis Patients
• Ladda ner fulltext (pdf) av Novel Biomarkers Detected by Proteomics Predict Death and Cardiovascular Events in Hemodialysis Patients

Multiplex proteomics as risk predictor of infection in patients treated with hemodialysis-A prospective multicenter study

Glerup, Rie; Svensson, My; Jakobsen, Lasse H.; Fellström, Bengt et al.

Ingår i Hemodialysis International, s. 191-201, 2022

• DOI för Multiplex proteomics as risk predictor of infection in patients treated with hemodialysis-A prospective multicenter study

Randomised clinical trial and meta-analysis: mesalazine treatment in irritable bowel syndrome-effects on gastrointestinal symptoms and rectal biomarkers of immune activity.

Castro Tejera, Valeria; Öhman, Lena; Aabakken, Lars; Fellström, Bengt et al.

Ingår i Alimentary Pharmacology and Therapeutics, s. 968-979, 2022

• DOI för Randomised clinical trial and meta-analysis: mesalazine treatment in irritable bowel syndrome-effects on gastrointestinal symptoms and rectal biomarkers of immune activity.
• Ladda ner fulltext (pdf) av Randomised clinical trial and meta-analysis: mesalazine treatment in irritable bowel syndrome-effects on gastrointestinal symptoms and rectal biomarkers of immune activity.

Association of Serum Phosphate with Efficacy of Statin Therapy in Hemodialysis Patients

Massy, Ziad A.; Merkling, Thomas; Wagner, Sandra; Girerd, Nicolas et al.

Ingår i American Society of Nephrology. Clinical Journal, s. 546-554, 2022

• DOI för Association of Serum Phosphate with Efficacy of Statin Therapy in Hemodialysis Patients

High cholesterol absorption is associated with increased cardiovascular risk in haemodialysis patients: insights from the AURORA study

Silbernagel, Gunther; Duarte, Kevin; Sadiku, Samir; Fauler, Günter et al.

Ingår i European Journal of Preventive Cardiology, s. 1731-1739, 2022

• DOI för High cholesterol absorption is associated with increased cardiovascular risk in haemodialysis patients: insights from the AURORA study

Osteoprotegerin predicts cardiovascular events in patients treated with haemodialysis

Wu, Ping-Hsun; Glerup, Rie Io; Svensson, My Hanna Sofia; Eriksson, Niclas et al.

Ingår i Nephrology, Dialysis and Transplantation, s. 1162-1170, 2021

• DOI för Osteoprotegerin predicts cardiovascular events in patients treated with haemodialysis

Albumin Urinary Excretion Is Associated with Increased Levels of Urinary Chemokines, Cytokines, and Growth Factors Levels in Humans

Fellström, Bengt; Helmersson Karlqvist, Johanna; Lind, Lars; Soveri, Inga et al.

Ingår i Biomolecules, 2021

• DOI för Albumin Urinary Excretion Is Associated with Increased Levels of Urinary Chemokines, Cytokines, and Growth Factors Levels in Humans
• Ladda ner fulltext (pdf) av Albumin Urinary Excretion Is Associated with Increased Levels of Urinary Chemokines, Cytokines, and Growth Factors Levels in Humans

Strong Associations Between Early Tubular Damage and Urinary Cytokine, Chemokine, and Growth Factor Levels in Elderly Males and Females

Fellström, Bengt; Helmersson, Johanna; Lind, Lars; Soveri, Inga et al.

Ingår i Journal of Interferon and Cytokine Research, s. 283-290, 2021

• DOI för Strong Associations Between Early Tubular Damage and Urinary Cytokine, Chemokine, and Growth Factor Levels in Elderly Males and Females

Associations of Bone Turnover Markers with Cognitive Function in Patients Undergoing Hemodialysis

Wu, Ping-Hsun; Lin, Yi-Ting; Chen, Cheng-Sheng; Chiu, Yi-Wen et al.

Ingår i Disease Markers, 2020

• DOI för Associations of Bone Turnover Markers with Cognitive Function in Patients Undergoing Hemodialysis
• Ladda ner fulltext (pdf) av Associations of Bone Turnover Markers with Cognitive Function in Patients Undergoing Hemodialysis

Arteriovenous fistula thrombosis is associated with increased all-cause and cardiovascular mortar in haemodialysis patients from the AURORA trial

Girerd, Sophie; Girerd, Nicolas; Frimat, Luc; Holdaas, Hallvard et al.

Ingår i Clinical Kidney Journal, s. 116-122, 2020

• DOI för Arteriovenous fistula thrombosis is associated with increased all-cause and cardiovascular mortar in haemodialysis patients from the AURORA trial
• Ladda ner fulltext (pdf) av Arteriovenous fistula thrombosis is associated with increased all-cause and cardiovascular mortar in haemodialysis patients from the AURORA trial

Improved cardiovascular risk prediction in patients with end-stage renal disease on hemodialysis using machine learning modeling and circulating microribonucleic acids

de Gonzalo-Calvo, David; Martinez-Camblor, Pablo; Baer, Christian; Duarte, Kevin et al.

Ingår i Theranostics, s. 8665-8676, 2020

• DOI för Improved cardiovascular risk prediction in patients with end-stage renal disease on hemodialysis using machine learning modeling and circulating microribonucleic acids
• Ladda ner fulltext (pdf) av Improved cardiovascular risk prediction in patients with end-stage renal disease on hemodialysis using machine learning modeling and circulating microribonucleic acids

Day-to-day variation of the kidney proximal tubular injury markers urinary cystatin C, KIM1, and NGAL in patients with chronic kidney disease

Soveri, Inga; Helmersson-Karlqvist, Johanna; Fellström, Bengt; Larsson, Anders

Ingår i Renal failure, s. 400-404, 2020

• DOI för Day-to-day variation of the kidney proximal tubular injury markers urinary cystatin C, KIM1, and NGAL in patients with chronic kidney disease
• Ladda ner fulltext (pdf) av Day-to-day variation of the kidney proximal tubular injury markers urinary cystatin C, KIM1, and NGAL in patients with chronic kidney disease

Is there long-term value of pathology scoring in immunoglobulin A nephropathy?: A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update

Coppo, Rosanna; D'Arrigo, Graziella; Tripepi, Giovanni; Russo, Maria Luisa et al.

Ingår i Nephrology, Dialysis and Transplantation, s. 1002-1009, 2020

• DOI för Is there long-term value of pathology scoring in immunoglobulin A nephropathy?: A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update

The association between Single Nucleotide Polymorphisms of Klotho Gene and Mortality in Elderly Men: The MrOS Sweden Study

Wu, Ping-Hsun; Westerberg, Per-Anton; Kindmark, Andreas; Tivesten, Åsa et al.

Ingår i Scientific Reports, 2020

• DOI för The association between Single Nucleotide Polymorphisms of Klotho Gene and Mortality in Elderly Men: The MrOS Sweden Study
• Ladda ner fulltext (pdf) av The association between Single Nucleotide Polymorphisms of Klotho Gene and Mortality in Elderly Men: The MrOS Sweden Study

Associations Between Apolipoprotein A1, High-Density Lipoprotein Cholesterol, and Urinary Cytokine Levels in Elderly Males and Females

Fellström, Bengt; Helmersson-Karlqvist, Johanna; Lind, Lars; Soveri, Inga et al.

Ingår i Journal of Interferon and Cytokine Research, s. 71-74, 2020

• DOI för Associations Between Apolipoprotein A1, High-Density Lipoprotein Cholesterol, and Urinary Cytokine Levels in Elderly Males and Females

Acute effects of haemodialysis on circulating microparticles

de Laval, Philip; Mobarrez, Fariborz; Almquist, Tora; Vassil, Liina et al.

Ingår i Clinical Kidney Journal, s. 456-462, 2019

• DOI för Acute effects of haemodialysis on circulating microparticles
• Ladda ner fulltext (pdf) av Acute effects of haemodialysis on circulating microparticles

Diagnostic Utility of Exome Sequencing for Kidney Disease

Groopman, Emily E.; Marasa, Maddalena; Cameron-Christie, Sophia; Petrovski, Slavé et al.

Ingår i New England Journal of Medicine, s. 142-151, 2019

• DOI för Diagnostic Utility of Exome Sequencing for Kidney Disease

Genetic markers associated with long term cardiovascular outcome in kidney transplant recipients

Pihlstrøm, Hege K; Mjøen, Geir; Mucha, Sören; Franke, Andre et al.

Ingår i American Journal of Transplantation, s. 1444-1451, 2019

• DOI för Genetic markers associated with long term cardiovascular outcome in kidney transplant recipients

Exome-Based Rare-Variant Analyses in CKD

Cameron-Christie, Sophia; Wolock, Charles J.; Groopman, Emily; Petrovski, Slave et al.

Ingår i Journal of the American Society of Nephrology, s. 1109-1122, 2019

• DOI för Exome-Based Rare-Variant Analyses in CKD

Evaluating a New International Risk-Prediction Tool in IgA Nephropathy

Barbour, Sean J.; Coppo, Rosanna; Zhang, Hong; Liu, Zhi-Hong et al.

Ingår i JAMA Internal Medicine, s. 942-952, 2019

• DOI för Evaluating a New International Risk-Prediction Tool in IgA Nephropathy

A Fully Automated Method for the Determination of Serum Belatacept and Its Application in a Pharmacokinetic Investigation in Renal Transplant Recipients

Klaasen, Rolf Anton; Egeland, Erlend Johannessen; Chan, Joe; Midtvedt, Karsten et al.

Ingår i Therapeutic Drug Monitoring, s. 11-18, 2019

• DOI för A Fully Automated Method for the Determination of Serum Belatacept and Its Application in a Pharmacokinetic Investigation in Renal Transplant Recipients

Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal Protection

Mafham, Marion M; Staplin, Natalie; Emberson, Jonathan; Haynes, Richard et al.

Ingår i Nephrology, Dialysis and Transplantation, s. 257-264, 2018

• DOI för Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal Protection
• Ladda ner fulltext (pdf) av Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal Protection

Adherence of Renal Transplant Recipients to Once-daily, Prolonged-Release and Twice-daily, Immediate-release Tacrolimus-based Regimens in a Real-life Setting in Sweden

Fellström, Bengt; Holmdahl, J.; Sundvall, N.; Cockburn, E. et al.

Ingår i Transplantation Proceedings, s. 3275-3282, 2018

• DOI för Adherence of Renal Transplant Recipients to Once-daily, Prolonged-Release and Twice-daily, Immediate-release Tacrolimus-based Regimens in a Real-life Setting in Sweden
• Ladda ner fulltext (pdf) av Adherence of Renal Transplant Recipients to Once-daily, Prolonged-Release and Twice-daily, Immediate-release Tacrolimus-based Regimens in a Real-life Setting in Sweden

Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation.

Storey, Benjamin C; Staplin, Natalie; Haynes, Richard; Reith, Christina et al.

Ingår i Kidney International, s. 1000-1007, 2018

• DOI för Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation.
• Ladda ner fulltext (pdf) av Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation.

Predictors of atherosclerotic events in patients on haemodialysis: post hoc analyses from the AURORA study.

Solbu, Marit D; Mjøen, Geir; Mark, Patrick B; Holdaas, Hallvard et al.

Ingår i Nephrology, Dialysis and Transplantation, s. 102-112, 2018

• DOI för Predictors of atherosclerotic events in patients on haemodialysis: post hoc analyses from the AURORA study.

Oxidized LDL, statin use, morbidity, and mortality in patients receiving maintenance hemodialysis

Wagner, Sandra; Apetrii, Mugurel; Massy, Ziad A.; Kleber, Marcus E. et al.

Ingår i Free radical research, s. 14-23, 2017

• DOI för Oxidized LDL, statin use, morbidity, and mortality in patients receiving maintenance hemodialysis

Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial

Fellström, Bengt C.; Barratt, Jonathan; Cook, Heather; Coppo, Rosanna et al.

Ingår i The Lancet, s. 2117-2127, 2017

• DOI för Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial

A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease

Schlackow, Iryna; Kent, Seamus; Herrington, William; Emberson, Jonathan et al.

Ingår i Heart, s. 1880-1890, 2017

• DOI för A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease
• Ladda ner fulltext (pdf) av A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease

Targeted-release budesonide therapy for IgA nephropathy - Authors' reply.

Fellström, Bengt; Barratt, Jonathan; Flöge, Jürgen; Jardine, Alan

Ingår i The Lancet, s. 2625-2626, 2017

• DOI för Targeted-release budesonide therapy for IgA nephropathy - Authors' reply.

Advancing Transplantation: New Questions, New Possibilities in Kidney and Liver Transplantation

Wadström, Jonas; Ericzon, Bo-Goran; Halloran, Philip F.; Bechstein, Wolf O. et al.

Ingår i Transplantation, 2017

• DOI för Advancing Transplantation: New Questions, New Possibilities in Kidney and Liver Transplantation
• Ladda ner fulltext (pdf) av Advancing Transplantation: New Questions, New Possibilities in Kidney and Liver Transplantation

Single Nucleotide Polymorphisms and Long-Term Clinical Outcome in Renal Transplant Patients: A Validation Study

Pihlstrøm, H. K.; Mjøen, G.; Mucha, S.; Haraldsen, G. et al.

Ingår i American Journal of Transplantation, s. 528-533, 2017

• DOI för Single Nucleotide Polymorphisms and Long-Term Clinical Outcome in Renal Transplant Patients: A Validation Study

Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials

Herrington, William; Emberson, Jonathan; Mihaylova, Borislava; Blackwell, Lisa et al.

Ingår i The Lancet Diabetes and Endocrinology, s. 829-839, 2016

• DOI för Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials
• Ladda ner fulltext (pdf) av Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials

Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP)

Staplin, Natalie; Haynes, Richard; Herrington, William G.; Reith, Christina et al.

Ingår i American Journal of Kidney Diseases, s. 371-380, 2016

• DOI för Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP)
• Ladda ner fulltext (pdf) av Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP)

Homoarginine and Clinical Outcomes in Renal Transplant Recipients: Results From the Assessment of Lescol in Renal Transplantation Study

Drechsler, Christiane; Pihlström, Hege; Meinitzer, Andreas; Pilz, Stefan et al.

Ingår i Transplantation, s. 1470-1476, 2015

• DOI för Homoarginine and Clinical Outcomes in Renal Transplant Recipients: Results From the Assessment of Lescol in Renal Transplantation Study

Increased Risk of All-Cause Mortality and Renal Graft Loss in Stable Renal Transplant Recipients With Hyperparathyroidism

Pihlstrom, Hege; Dahle, Dag Olav; Mjoen, Geir; Pilz, Stefan et al.

Ingår i Transplantation, s. 351-359, 2015

• DOI för Increased Risk of All-Cause Mortality and Renal Graft Loss in Stable Renal Transplant Recipients With Hyperparathyroidism

NON-TRADITIONAL CARDIOVASCULAR RISK FACTORS PREDOMINATE IN HEMODIALYSIS PATIENTS WITH PRE-EXISTIN CARDIOVASCULAR DISEASE

Naess, Hege; Zannad, Faiez; Jardine, Alan G.; Schmieder, Roland E. et al.

Ingår i Nephrology, Dialysis and Transplantation, 2015

Immunological Profiling of Haemodialysis Patients and Young Healthy Individuals with Implications for Clinical Regulatory T Cell Sorting

Bergström, Marcus; Joly, A. -L; Seiron, P.; Isringhausen, S. et al.

Ingår i Scandinavian Journal of Immunology, s. 318-324, 2015

• DOI för Immunological Profiling of Haemodialysis Patients and Young Healthy Individuals with Implications for Clinical Regulatory T Cell Sorting

Pulse Pressure Superior to Systolic or Diastolic Blood Pressure in Predicting Mortality in Hemodialysis Patients

Mjoen, Geir; Zannad, Faiez; Jardine, Alan; Schmieder, Roland et al.

Ingår i Nephrology, Dialysis and Transplantation, s. 79-79, 2014

Symmetric Dimethylarginine as Predictor of Graft Loss and All-Cause Mortality in Renal Transplant Recipients

Pihlstrom, H.; Mjoen, G.; Dahle, D.; Pilz, S. et al.

Ingår i American Journal of Transplantation, s. 102-102, 2014

Hyperparathyroidism in Stable Renal Transplant Recipients Is Associated With All-Cause Mortality and Renal Graft Loss

Pihlstrom, H.; Dahle, D.; Mjoen, G.; Pilz, S. et al.

Ingår i American Journal of Transplantation, s. 126-126, 2014

Symmetric Dimethylarginine as Predictor of Graft Loss and All-Cause Mortality in Renal Transplant Recipients

Pihlstrom, H.; Mjoen, G.; Dahle, D.; Pilz, S. et al.

Ingår i Transplantation, s. 102-102, 2014

Hyperparathyroidism in Stable Renal Transplant Recipients Is Associated With All-Cause Mortality and Renal Graft Loss

Pihlstrom, H.; Dahle, D.; Mjoen, G.; Pilz, S. et al.

Ingår i Transplantation, s. 126-126, 2014

Symmetric Dimethylarginine as Predictor of Graft loss and All-Cause Mortality in Renal Transplant Recipients

Pihlstrom, Hege; Mjoen, Geir; Dahle, Dag Olav; Pilz, Stefan et al.

Ingår i Transplantation, s. 1219-1225, 2014

• DOI för Symmetric Dimethylarginine as Predictor of Graft loss and All-Cause Mortality in Renal Transplant Recipients

Effects of Lowering LDL Cholesterol on Progression of Kidney Disease

Haynes, Richard; Lewis, David; Emberson, Jonathan; Reith, Christina et al.

Ingår i Journal of the American Society of Nephrology, s. 1825-1833, 2014

• DOI för Effects of Lowering LDL Cholesterol on Progression of Kidney Disease

Homoarginine and Clinical Outcomes in Renal Transplant Recipients: Results from the Alert Study

Drechsler, Christiane; Philstrom, Hege; Meinitzer, Andreas; Pilz, Stefan et al.

Ingår i Nephrology, Dialysis and Transplantation, s. 539-539, 2014

Risk Factors for Stroke in Hemodialysis Patients

Nilssen, Camilla; Zannad, Faiez; Jardine, Alan; Schmieder, Roland et al.

Ingår i Nephrology, Dialysis and Transplantation, s. 484-484, 2014

Risk Factors for Cardiovascular Events and All-Cause Mortality in Diabetic Hemodialysis Patients

Naess, Hege; Fellström, Bengt; Jardine, Alan G.; Schmieder, Roland E. et al.

Ingår i Nephrology, Dialysis and Transplantation, s. 487-487, 2014

Functional Cardiopulmonary Exercise Testing in Potential Renal Transplant Recipients

Fellström, Bengt; Holdaas, Hallvard; Jardine, Alan

Ingår i Journal of the American Society of Nephrology, s. 8-9, 2014

• DOI för Functional Cardiopulmonary Exercise Testing in Potential Renal Transplant Recipients

Neopterin is associated with cardiovascular events and all-cause mortality in renal transplant patients

Pihlstrom, Hege; Mjoen, Geir; Maerz, Winfried; Dahle, Dag Olav et al.

Ingår i Clinical Transplantation, s. 111-119, 2014

• DOI för Neopterin is associated with cardiovascular events and all-cause mortality in renal transplant patients
• Ladda ner fulltext (pdf) av Neopterin is associated with cardiovascular events and all-cause mortality in renal transplant patients

The effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal Protection

Herrington, William; Emberson, Jonathan; Staplin, Natalie; Blackwell, Lisa et al.

Ingår i Clinical journal of the American Society of Nephrology : CJASN, s. 914-919, 2014

• DOI för The effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal Protection

Risk Factors and Management Options for Cardiovascular Disease (CVD) in Kidney Transplantation

Fellström, Bengt

Ingår i Annals of Saudi Medicine, 2013

Anemia is a predictor of graft loss but not cardiovascular events and all-cause mortality in renal transplant recipients: follow-up data from the ALERT study

Schjelderup, Patrick; Dahle, Dag Olav; Holdaas, Hallvard; Mjoen, Geir et al.

Ingår i Clinical Transplantation, 2013

• DOI för Anemia is a predictor of graft loss but not cardiovascular events and all-cause mortality in renal transplant recipients: follow-up data from the ALERT study

Model Comparisons of Competing Risk and Recurrent Events for Graft Failure in Renal Transplant Recipients

Holme, Ingar; Fellström, Bengt C.; Jardine, Alan G.; Hartmann, Anders et al.

Ingår i American Society of Nephrology. Clinical Journal, s. 241-247, 2013

• DOI för Model Comparisons of Competing Risk and Recurrent Events for Graft Failure in Renal Transplant Recipients

The External Validation of the Cardiovascular Risk Equation for Renal Transplant Recipients: Applications to BENEFIT and BENEFIT-EXT Trials

Soveri, Inga; Snyder, Jon; Holdaas, Hallvard; Holme, Ingar et al.

Ingår i Transplantation, s. 142-147, 2013

• DOI för The External Validation of the Cardiovascular Risk Equation for Renal Transplant Recipients: Applications to BENEFIT and BENEFIT-EXT Trials

Determinants of Cardiovascular Risk in Haemodialysis Patients: Post hoc Analyses of the AURORA Study

Schneider, Andreas; Jardine, Alan G.; Schneider, Markus P.; Holdaas, Hallvard et al.

Ingår i American Journal of Nephrology, s. 144-151, 2013

• DOI för Determinants of Cardiovascular Risk in Haemodialysis Patients: Post hoc Analyses of the AURORA Study

Graft Loss Risk in Renal Transplant Recipients with Metabolic Syndrome: Subgroup Analyses of the ALERT Trial

Soveri, Inga; Abedini, Sadollah; Holdaas, Halvard; Jardine, Alan et al.

Ingår i JN. Journal of Nephrology (Milano. 1992), s. 245-254, 2012

• DOI för Graft Loss Risk in Renal Transplant Recipients with Metabolic Syndrome: Subgroup Analyses of the ALERT Trial

In vitro and in vivo toxicity of rinsed and aged nanocellulose-polypyrrole composites

Ferraz, Natalia; Strømme, Maria; Fellström, Bengt; Pradhan, Sulena et al.

Ingår i Journal of Biomedical Materials Research. Part A, s. 2128-2138, 2012

• DOI för In vitro and in vivo toxicity of rinsed and aged nanocellulose-polypyrrole composites

Conducting Nanocellulose Polypyrrole Membranes Intended for Hemodialysis

Carlsson, Daniel O; Ferraz, Natalia; Hong, Jaan; Larsson, Rolf et al.

Ingår i European Cells & Materials, s. 32-32, 2012

Haemocompatibility and ion exchange capability of nanocellulose polypyrrole membranes intended for blood purification

Ferraz, Natalia; Carlsson, Daniel O.; Hong, Jaan; Larsson, Rolf et al.

Ingår i Journal of the Royal Society Interface, s. 1943-1955, 2012

• DOI för Haemocompatibility and ion exchange capability of nanocellulose polypyrrole membranes intended for blood purification

Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study

Svensson, My; Dahle, Dag Olav; Mjoen, Geir; Weihrauch, Gisela et al.

Ingår i Nephrology, Dialysis and Transplantation, s. 2571-2575, 2012

• DOI för Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study

Prognostic model for total mortality in patients with haemodialysis from the Assessments of Survival and Cardiovascular Events (AURORA) study

Holme, I.; Fellström, Bengt C.; Jardin, A. G.; Schmieder, R. E. et al.

Ingår i Journal of Internal Medicine, s. 463-471, 2012

• DOI för Prognostic model for total mortality in patients with haemodialysis from the Assessments of Survival and Cardiovascular Events (AURORA) study

A Cardiovascular Risk Calculator for Renal Transplant Recipients

Soveri, Inga; Holme, Ingar; Holdaas, Hallvard; Budde, Klemens et al.

Ingår i Transplantation, s. 57-62, 2012

• DOI för A Cardiovascular Risk Calculator for Renal Transplant Recipients

Cardioprotective role of statins in chronic kidney disease: do we have the answer?

Fellström, Bengt

Ingår i Kidney International, s. 931-932, 2011

• DOI för Cardioprotective role of statins in chronic kidney disease: do we have the answer?

Rosuvastatin in Diabetic Hemodialysis Patients

Holdaas, Hallvard; Holme, Ingar; Schmieder, Roland E.; Jardine, Alan G. et al.

Ingår i Journal of the American Society of Nephrology, s. 1335-1341, 2011

• DOI för Rosuvastatin in Diabetic Hemodialysis Patients

Conversion of Long-Term Kidney Transplant Recipients From Calcineurin Inhibitor Therapy to Everolimus: A Randomized, Multicenter, 24-Month Study

Holdaas, Hallvard; Rostaing, Lionel; Seron, Daniel; Cole, Edward et al.

Ingår i Transplantation, s. 410-418, 2011

• DOI för Conversion of Long-Term Kidney Transplant Recipients From Calcineurin Inhibitor Therapy to Everolimus: A Randomized, Multicenter, 24-Month Study

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

Baigent, Colin; Landray, Martin J.; Reith, Christina; Emberson, Jonathan et al.

Ingår i The Lancet, s. 2181-2192, 2011

• DOI för The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

New Treatment of IgA nephropathy: Enteric Budesonide Targeted to the Ileocaecal Region Ameliorates Proteinuria

Kloster Smerud, Hilde; Bárány, Peter; Lindström, Karin; Fernström, Anders et al.

Ingår i Nephrology, Dialysis and Transplantation, s. 3237-3242, 2011

• DOI för New Treatment of IgA nephropathy: Enteric Budesonide Targeted to the Ileocaecal Region Ameliorates Proteinuria

Organ Transplantation 2: Prevention of cardiovascular disease in adult recipients of kidney transplants

Jardine, Alan G.; Gaston, Robert S.; Fellström, Bengt C.; Holdaas, Hallvard

Ingår i The Lancet, s. 1419-1427, 2011

• DOI för Organ Transplantation 2: Prevention of cardiovascular disease in adult recipients of kidney transplants

Inflammation-associated graft loss in renal transplant recipients

Dahle, Dag Olav; Mjoen, Geir; Oqvist, Bjorn; Scharnagl, Hubert et al.

Ingår i Nephrology, Dialysis and Transplantation, s. 3756-3761, 2011

• DOI för Inflammation-associated graft loss in renal transplant recipients

Intragraft Cytomegalovirus Protein Expression Is Associated With Reduced Renal Allograft Survival

Dzabic, Mensur; Rahbar, Afsar; Yaiw, Koon-Chu; Naghibi, Mansour et al.

Ingår i Clinical Infectious Diseases, s. 969-976, 2011

• DOI för Intragraft Cytomegalovirus Protein Expression Is Associated With Reduced Renal Allograft Survival

Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients

Abedini, Sadollah; Meinitzer, Andreas; Holme, Ingar; März, Winfried et al.

Ingår i Kidney International, s. 44-50, 2010

• DOI för Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients

Comparison of predictive ability of lipoprotein components to that of traditional risk factors of coronary events in renal transplant recipients

Holme, Ingar; Fellström, Bengt; Jardine, Alan; Holdaas, Halvard

Ingår i Atherosclerosis, s. 234-239, 2010

• DOI för Comparison of predictive ability of lipoprotein components to that of traditional risk factors of coronary events in renal transplant recipients

Gastrointestinal sensitivity to soy and milk proteins in patients with IgA nephropathy

Kloster Smerud, Hilde; Fellström, Bengt; Hällgren, Roger; Osagie, Sonia et al.

Ingår i Clinical Nephrology, s. 364-371, 2010

RISK FACTOR ANALYSIS OF CARDIOVASCULAR EVENTS IN PATIENTS ON HAEMODIALYSIS (THE AURORA STUDY)

Schmieder, R.; Fellström, Bengt; Holdaas, H.; Gottlow, M. et al.

Ingår i Journal of Hypertension, 2010

Cerebrovascular events in renal transplant recipients

Abedini, Sadollah; Holme, Ingar; Fellström, Bengt; Jardine, Alan et al.

Ingår i Transplantation, s. 112-7, 2009

• DOI för Cerebrovascular events in renal transplant recipients

Inflammation in renal transplantation

Abedini, Sadollah; Holme, Ingar; März, Winfried; Weihrauch, Gisela et al.

Ingår i Journal of the American Society of Nephrology, s. 1246-1254, 2009

• DOI för Inflammation in renal transplantation

Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus:  a randomized placebo-controlled study

Norby, Gudrun Elisabeth; Holme, Ingar; Fellström, Bengt; Jardine, Alan et al.

Ingår i Arthritis and Rheumatism, s. 1060-1064, 2009

• DOI för Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus:  a randomized placebo-controlled study

Rosuvastatin and Cardiovascuular Events in Patients Undergoing Hemodialysis

Fellström, Bengt; Jardine, Alan G.; Scmieder, R.E.; Holdaas, H. et al.

Ingår i New England Journal of Medicine, s. 1395-1407, 2009

• DOI för Rosuvastatin and Cardiovascuular Events in Patients Undergoing Hemodialysis

Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patients survival

Snaedal, Sunna; Heimburger, Olof; Qureshi, Abdul Rashid; Danielsson, Anders et al.

Ingår i American Journal of Kidney Diseases, s. 1024-1033, 2009

• DOI för Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patients survival

Rosuvastatin in Patients Undergoing Hemodialysis REPLY

Fellström, Bengt; Jardine, Alan; Holdaas, Hallvard

Ingår i New England Journal of Medicine, s. 94-95, 2009

Gluten sensitivity in patients with IgA nephropathy

Smerud, Hilde Kloster; Fellström, Bengt; Hällgren, Roger; Osagie, Sonia et al.

Ingår i Nephrology, Dialysis and Transplantation, s. 2476-2481, 2009

• DOI för Gluten sensitivity in patients with IgA nephropathy

Kidney function and discrimination of cardiovascular risk in middle-aged men

Soveri, Inga; Ärnlöv, Johan; Berglund, Lars; Lind, Lars et al.

Ingår i Journal of Internal Medicine, s. 406-413, 2009

• DOI för Kidney function and discrimination of cardiovascular risk in middle-aged men

Telomere attrition is associated with inflammation, low fetuin: A levels and high mortality in prevalent haemodialysis patients

Carrero, J.J.; Stenvinkel, Peter; Fellström, Bengt; Qureshi, A.R. et al.

Ingår i Journal of Internal Medicine, s. 302-312, 2008

• DOI för Telomere attrition is associated with inflammation, low fetuin: A levels and high mortality in prevalent haemodialysis patients

Improvement in Central Arterial Pressure Waveform during Hemodialysis Is Related to a Reduction in Asymmetric Dimethylarginine (ADMA) Levels

Soveri, Inga; Lind, Lars; Wikström, Björn; Zilmer, Mihkel et al.

Ingår i Nephron. Clinical practice, 2007

• DOI för Improvement in Central Arterial Pressure Waveform during Hemodialysis Is Related to a Reduction in Asymmetric Dimethylarginine (ADMA) Levels

Effect of Rosuvastatin on Outcomes in Chronic Haemodialysis Patients: Baseline Data from the AURORA Study

Fellström, Bengt; Zannad, Faiez; Schmieder, Roland; Holdaas, Hallvard et al.

Ingår i Kidney and Blood Pressure Research, s. 314-322, 2007

• DOI för Effect of Rosuvastatin on Outcomes in Chronic Haemodialysis Patients: Baseline Data from the AURORA Study

Genetic analysis of fluvastatin response and dyslipidemia in renal transplant recipients

Singer, J.B.; Holdaas, Hallvard; Jardine, Alan G.; Fellström, Bengt et al.

Ingår i Journal of Lipid Research, s. 2072-2078, 2007

• DOI för Genetic analysis of fluvastatin response and dyslipidemia in renal transplant recipients

Measurements of chromogranin B can serve as a complement to chromogranin A

Stridsberg, Mats; Eriksson, Barbro; Fellström, Bengt; Kristiansson, Gudjon et al.

Ingår i Regulatory Peptides, s. 80-83, 2007

• DOI för Measurements of chromogranin B can serve as a complement to chromogranin A

Renal transplant dysfunction - importance quantified in comparison with traditional risk factors for cardiovascular disease and mortality

Soveri, Inga; Holdaas, Hallvard; Jardine, Alan; Gimpelewicz, Claudio et al.

Ingår i Nephrology, Dialysis and Transplantation, s. 2282-2289, 2006

• DOI för Renal transplant dysfunction - importance quantified in comparison with traditional risk factors for cardiovascular disease and mortality

Erythropoietin impairs endothelial vasodilatory function in patients with renal anemia and in healthy subjects

Annuk, Margus; Linde, Torbjörn; Lind, Lars; Fellström, Bengt

Ingår i Nephron. Clinical practice, 2006

• DOI för Erythropoietin impairs endothelial vasodilatory function in patients with renal anemia and in healthy subjects

Ischemia-induced renal expression of hyaluronan and CD44 in diabetic rats

Melin, Jan; Hellberg, Olof; Funa, Keiko; Hällgren, Roger et al.

Ingår i Nephron. Experimental nephrology, 2006

• DOI för Ischemia-induced renal expression of hyaluronan and CD44 in diabetic rats

Risk factors for reaching renal endpoints in the assessment of Lescol in renal transplantation (ALERT) trial

Fellström, Bengt; Holdaas, Hallvard; Jardine, Alan G.; Nyberg, Gudrun et al.

Ingår i Transplantation, s. 205-212, 2005

Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation

Holdaas, Hallvard; Fellström, Bengt; Jardine, Alan G.; Nyberg, Gudrun et al.

Ingår i Nephrology, Dialysis and Transplantation, s. 974-980, 2005

• DOI för Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation

Renal dysfunction as a risk factor for mortality and cardiovascular disease in renal transplantation: experience from the Assessment of Lescol in Renal Transplantation trial

Fellström, Bengt; Jardine, Alan G.; Soveri, Inga; Cole, Edward et al.

Ingår i Transplantation, s. 1160-1163, 2005

Renal dysfunction is a strong and independent risk factor for mortality and cardiovascular complications in renal transplantation

Fellström, Bengt; Jardine, Alan G.; Soveri, Inga; Cole, E. et al.

Ingår i American Journal of Transplantation, s. 1986-1991, 2005

• DOI för Renal dysfunction is a strong and independent risk factor for mortality and cardiovascular complications in renal transplantation

Endothelial function, CRP and oxidative stress in chronic kidney disease

Annuk, Margus; Soveri, Inga; Zilmer, Mihkel; Lind, Lars et al.

Ingår i JN. Journal of Nephrology (Milano. 1992), s. 721-726, 2005

Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial

Fellström, Bengt; Holdaas, Hallvard; Jardine, Alan G.; Holme, Ingar et al.

Ingår i Kidney International, s. 1549-1555, 2004

• DOI för Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial

Cardiovascular Disease in Renal Transplantation-Management by Statins

Fellstrom, Bengt; Holdaas, H; Jardine, A

Ingår i Transplant Review, 2004

Cyclosporine nephrotoxicity

Fellstrom, Bengt

Ingår i Transplantation Proceedings, 2004

Donor antigen Independent Risk Factors for Chronic Allograft Nephropathy

Fellstrom, Bengt

Ingår i Transplant Review, s. 61-66, 2004

Endothelium-dependent vasodilation and oxidative stress in chronic renal failure: impact on cardiovascular disease

Annuk, Margus; Zilmer, Mihkel; Fellström, Bengt

Ingår i Kidney International, Supplement, 2003

Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial.

Holdaas, Hallvard; Fellstrom, Bengt; Jardine, Alan G; Holme, Ingar et al.

Ingår i Lancet, s. 2024-31, 2003

Hyperglycaemia and renal ischaemia-reperfusion injury.

Melin, Jan; Hellberg, Olof; Fellström, Bengt

Ingår i Nephrol Dial Transplant, s. 460-2, 2003

Cyclooxygenase inhibition improves endothelium-dependent vasodilatation in patients with chronic renal failure

Annuk, Margus; Fellström, Bengt; Lind, Lars

Ingår i Nephrology, Dialysis and Transplantation, s. 2159-2163, 2002

• DOI för Cyclooxygenase inhibition improves endothelium-dependent vasodilatation in patients with chronic renal failure

Serum levels of antibodies against oxidised LDL in kidney graft recipients.

Zezina, Lelija; Dimeny, Emoke; Vessby, Bengt; Fellstrom, Bengt

Ingår i Am J Nephrol, s. 539-47, 2002

Impaired endothelium-dependent vasodilatation in renal failure in humans

Annuk, Margus; Lind, Lars; Linde, Torbjörn; Fellström, Bengt

Ingår i Nephrology, Dialysis and Transplantation, s. 302-306, 2001

• DOI för Impaired endothelium-dependent vasodilatation in renal failure in humans

Oxidative stress and endothelial function in chronic renal failure

Annuk, Margus; Zilmer, Mikhel; Lind, Lars; Linde, Torbjörn et al.

Ingår i Journal of the American Society of Nephrology, s. 2747-2752, 2001

Oxidative stress markers in pre-uremic patients

Annuk, Margus; Fellström, Bengt; Åkerblom, O.; Zilmer, K. et al.

Ingår i Clinical Nephrology, s. 308-314, 2001

Effects of fluvastatin on cardiac events in renal transplant recipients

Holdaas, Hallvard; Fellstrom, Bengt; Holme, I; Nyberg, Gudrun et al.

Ingår i J Cardiovasc Risk, s. 63-71, 2001

Progression of chronic renal transplant dysfunction

Fellstrom, Bengt

Ingår i Transplantation Proceedings, s. 3355-6, 2001

Pathophysiology of progression of chronic graft dysfunction

Fellstrom, Bengt

Ingår i Transplantation Proceedings, s. 299-301, 2001

Risk factors for and Management of Post-Transplantation Cardiovascular Disease

Fellstrom, Bengt

Ingår i BioDrugs, s. 261-278, 2001

Apoptosis - Friend or Foe

Fellstrom, Bengt; Zezina, L

Ingår i Transplantation Proceedings, s. 2414-6, 2001

Angiotensin II receptor type I blocker Candesartan cilexetil reduces the development of chronic rejection in rat aortic grafts

Zezina, L; Larsson, E; Fellstrom, Bengt

Ingår i Transplant Immunology, s. 245-51, 2001

Non-immune risk factors for chronic renal allograft dysfunction

Fellstrom, Bengt

Ingår i Transplantation, 2001

Evaluation of endothelium-dependent vasodilation in the human peripheral circulation

Lind, Lars; Hall, Jan; Larsson, Anders; Annuk, Margus et al.

Ingår i Clinical Physiology, s. 440-448, 2000

• DOI för Evaluation of endothelium-dependent vasodilation in the human peripheral circulation

Recommendations for pre-analytical urine sample handling to allow optimal assessment of albuminuria and proteinuria

Ridderbos, Stefan; van Mil, Dominique; Fellström, Bengt; Gillespie, Barbara S. et al.

Ingår i Nephrology, Dialysis and Transplantation, 2026

• DOI för Recommendations for pre-analytical urine sample handling to allow optimal assessment of albuminuria and proteinuria
• Ladda ner fulltext (pdf) av Recommendations for pre-analytical urine sample handling to allow optimal assessment of albuminuria and proteinuria

Cardiovascular disease in haemodialysis: role of the intravascular innate immune system.

Ekdahl, Kristina N; Soveri, Inga; Hilborn, Jöns; Fellström, Bengt et al.

Ingår i Nature Reviews Nephrology, s. 285-296, 2017

• DOI för Cardiovascular disease in haemodialysis: role of the intravascular innate immune system.

Prevention of cardiovascular disease after renal transplantation

Svensson, My; Jardine, Alan; Fellström, Bengt; Holdaas, Hallvard

Ingår i Current Opinion in Organ Transplantation, s. 393-400, 2012

• DOI för Prevention of cardiovascular disease after renal transplantation

Cardiovascular disease in renal transplant recipients

McQuarrie, EP; Fellström, Bengt; Holdaas, H; Jardine, AG

Ingår i Journal of Renal Care, s. 136-145, 2010

• DOI för Cardiovascular disease in renal transplant recipients

Cardiovascular disease in patients with renal disease: the role of statins

Fellström, Bengt; Holdaas, Hallvard; Jardine, Alan G.; Svensson, Maria K. et al.

Ingår i Current Medical Research and Opinion, s. 271-285, 2009

• DOI för Cardiovascular disease in patients with renal disease: the role of statins

Chronic allograft nepropathy

Fellström, Bengt C.; Jardine, Alan; Holdaas, Hallvard

Ingår i Evidence-based nephrology, s. 599-608, Wiley-Blackwell, 2009

Lipid abnormalities in solid organ transplant recipients

Holdaas, Halvard; Fellström, Bengt; Jardine, Alan

Ingår i Clinical lipidology, s. 486-499, Saunders/Elsevier, 2009

Towards blood purification applications of polypyrrole and cellulose nanocomposites

Carlsson, Daniel O; Ferraz, Natalia; Fellström, Bengt; Nyholm, Leif et al.

2013

Hemocompatibility of Nanocellulose Polypyrrole Membranes Intended for Hemodialysis

Ferraz, Natalia; Carlsson, Daniel O; Hong, Jaan; Larsson, Rolf et al.

Ingår i 9th World Biomaterials Congress, June 1-5, 2012, Chengdu, China, 2012

Development of Nanocellulose/Polypyrrole Composites Towards Blood Purification

Carlsson, Daniel O; Nyström, Gustav; Ferraz, Natalia; Shou, Qi et al.

Ingår i Euromembrane 2012, Queen Elizabeth II Conference Centre, London, UK, 23-27 September 2012, 2012

Conduting nanocellulose polypyrrole membranes intended for hemodialysis

Carlsson, Daniel O; Ferraz, Natalie; Hong, J; Larsson, R et al.

2012

Novel biomarkers detected by proteomics predict death and cardiovascular events in hemodialysis patients

Wu, Ping-Hsun; Glerup, Rie Io; Svensson, My Hanna Sofia; Eriksson, Niclas et al.

The effect of fibroblast growth factor 23, vitamin D, and renal function on all-cause and cardiovascular mortality: The MrOS Sweden Study

Wu, Ping-Hsun; Westerberg, Per-Anton; Karlsson, Magnus K.; Mellström, Dan et al.

Cardiovascular risk in renal transplantation

Fellström, Bengt; Holdaas, Hallvard; Jardine, Alan

Ingår i Trends in Transplantation, s. 92-100, 2008

Lipid abnormalities in solid organ transplant recipients. Ballantyne et al

Holdaas, H; Fellström, Bengt; Jardine, Alan

Ingår i Clinical Lipidology, s. 486-499, 2008